Cargando…
Drug desensitization in the coronavirus disease 2019 pandemic era: Local success to widespread potential
Autores principales: | Blumenthal, Kimberly G., Castells, Mariana, Banerji, Aleena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997944/ https://www.ncbi.nlm.nih.gov/pubmed/33781932 http://dx.doi.org/10.1016/j.anai.2021.03.026 |
Ejemplares similares
-
Ceftaroline Desensitization Procedure in a Pregnant Patient With Multiple Drug Allergies
por: Kuhlen, James L., et al.
Publicado: (2015) -
Utilizing Biologics in Drug Desensitization
por: Yang, Barbara C., et al.
Publicado: (2022) -
Drug allergy labeling and delabeling in the coronavirus disease 2019 era: What is important and what do we need to know
por: Castells, Mariana C.
Publicado: (2020) -
Drug Hypersensitivity and Anaphylaxis in Cancer and Chronic Inflammatory Diseases: The Role of Desensitizations
por: Castells, Mariana
Publicado: (2017) -
Drug Hypersensitivity and Desensitizations: Mechanisms and New Approaches
por: de las Vecillas Sánchez, Leticia, et al.
Publicado: (2017)